Day: August 3, 2020
Certain Stakeholders Convert to EquityHOUSTON, TX, Aug. 03, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Viking Energy Group, Inc. (OTCQB: VKIN) (“Viking” or the “Company”) is pleased to announce that between June 30, 2020, and July 31, 2020, the Company reduced its overall debt by approximately $7,808,661. Approximately $1,705,982 of such reduction was on account of scheduled principal payments made on or about June 30th and July 31st by Viking’s subsidiaries under senior secured credit facilities, using cash on hand in the applicable subsidiary. Details regarding the senior credit facilities to which Viking’s subsidiaries are party were included in Viking’s Annual Report on Form 10-K filed on March 30, 2020, for the year ended December 31, 2019, which is available under “Investors — SEC Filings” at www.vikingenergygroup.com.Approximately...
Flushing Financial Corporation and Empire Bancorp, Inc. Announce Continued Merger Discussions
Written by Customer Service on . Posted in Public Companies.
UNIONDALE and ISLANDIA, N.Y., Aug. 03, 2020 (GLOBE NEWSWIRE) — Flushing Financial Corporation (“Flushing”) (Nasdaq‑GS: FFIC), parent company of Flushing Bank, and Empire Bancorp, Inc. (“Empire”) (OTC: EMPK), announced today that they have each advised the other they will not exercise their respective rights to terminate the Agreement and Plan of Merger, dated October 24, 2019, as amended, as would otherwise be permitted after July 31st by the terms of the merger agreement. Flushing and Empire are engaged in discussions for a longer term extension of time to complete the merger. About Flushing Financial CorporationFlushing Financial Corporation (Nasdaq-GS: FFIC) is the holding company for Flushing Bank®, a New York State-chartered commercial bank insured by the Federal Deposit Insurance Corporation. Flushing Bank serves consumers,...
Making Our COVID Survivors Whole Again By Solving Yet Another Desperate Shortage
Written by Customer Service on . Posted in Public Companies.
LOS ANGELES, CA, Aug. 03, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – US Nuclear Corp. (OTC: UCLE) aims to combat COVID-19 and help patients and survivors of the virus by working together with MIFTEC to produce an unlimited supply of domestic, low-cost medical isotopes. The IAEA is supporting more than 121 countries with RT-PCR equipment, which is used to rapidly detect COVID-19 in real-time by a nuclear-derived technique and is one of the most widely used and accurate lab methods. The isotope Co-60 is also being used to sterilize medical equipment, devices, and supplies for COVID-19 professionals to ensure they are safe for use. Co-60 irradiation is one of the quickest and most effective methods for sterilizing large volumes of this equipment. Medical isotopes and nuclear medicine are proving to be effective in sterilizing,...
Beazley builds Midwest presence with four cyber & executive risk underwriting hires
Written by Customer Service on . Posted in Public Companies.
New York, Aug. 03, 2020 (GLOBE NEWSWIRE) — Specialist insurer Beazley has appointed four new underwriters within its Chicago-based cyber & executive risk (CyEx) division to add expertise and support growth across the business. Jon Perry and Megan Feyereisen join as executive risk underwriters, while Brett Kreiter and Rich Michaels will underwrite cyber and technology errors & omissions (E&O).Bethany Greenwood, global head of cyber & executive risk at Beazley, said: “We have an incredible team and we’re excited to continue to strengthen this division, and particularly to build out our offering in the Midwest. Jon, Megan, Brett and Rich bring significant underwriting and leadership experience, as we continue to serve our brokers and clients and build on the strong growth we have seen in the US over recent months.”Jon...
MyoKardia Doses First Patient in Phase 3 VALOR-HCM Trial of Mavacamten
Written by Customer Service on . Posted in Public Companies.
BRISBANE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) announced that the first patient has been dosed in the Phase 3 VALOR-HCM clinical trial. VALOR-HCM will enroll individuals with obstructive hypertrophic cardiomyopathy (HCM) who have been referred for septal reduction therapy (SRT) and are refractory to current therapeutic options, including those who have severe symptoms (NYHA Class IV). VALOR-HCM is designed to provide direct clinical evidence of mavacamten’s ability to mitigate the need for invasive SRT procedures and is the first of several potential studies planned by MyoKardia to expand on the existing body of evidence supporting mavacamten’s use as a potential backbone therapy for HCM. VALOR-HCM is being conducted in partnership with Cleveland Clinic C5Research, an academic research organization,...
C-Bond Systems Reports Record Monthly Revenue of $128,000 in July
Written by Customer Service on . Posted in Public Companies.
HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has reported record monthly revenue of more than $128,000 in July driven by robust sales of the Company’s nanoproducts.Unaudited revenue generated in July was primarily a result of robust sales of C-Bond NanoShield™, the Company’s patented windshield strengthener, and an order for MB-10 Tablets from an overseas distributor. In the first quarter of 2020, C-Bond Systems delineated its business model into the Transportation Solutions Group and Safety Solutions Group in order to expand and better position its business for strategic partnership opportunities. C-Bond Transportation Solutions includes the C-Bond NanoShield™ product line and C-Bond Safety Solutions includes C-Bond...
OSS Discusses Edge Computing and AI on the Fly® in Noble Capital Markets Video Interview
Written by Customer Service on . Posted in Public Companies.
ESCONDIDO, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (Nasdaq: OSS), a leader in specialized high-performance edge computing, has been featured in Noble Capital Markets’ C-Suite Interview Series, presented by Channelchek. Noble Capital Markets’ senior equity analyst, Joe Gomes, interviewed the new president and CEO of One Stop Systems, David Raun.Topics covered:What makes the OSS product portfolio unique?Market size, growth and competitive environment.Transformational changes since Raun became CEO.COVID-19 impact on manufacturing, supply, and customers.Plans to enhance the company’s value proposition.Biggest near-term growth opportunity.The video interview is available today on Channelchek by clicking here. The Noble analyst’s research report on OSS is available via the same link.About Noble Capital MarketsNoble...
Conversion Labs July 2020 Revenues up 302% to Record $3.6 Million, Remains on Track to Exceed $40 Million in Revenue in 2020
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported record revenues of $3.6 million in the month of July, up more than 302% versus July 2019.For July 2020, $1.2 million was attributed to recurring revenue from rebilled subscriptions to products and services, up 362% versus July 2019. “Revenue, and particularly recurring subscription revenue, has grown across the board due to the strategic investments we’ve made in our brands, our people and our digital health platform,” commented Justin Schreiber, CEO of Conversion Labs.“When we connect with a customer seeking treatment, it usually represents the beginning of a long-term relationship between provider and patient,” continued Schreiber. “Our goal is to do everything possible to deliver great...
Celldex to Report Second Quarter 2020 Financial Results and Host Corporate Update Call
Written by Customer Service on . Posted in Public Companies.
HAMPTON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) will report second quarter 2020 financial results on Thursday, August 6, 2020 after the U.S. financial markets close. Celldex executives will host a conference call at 4:30 p.m. EDT on the same day to review the second quarter financial results and to provide an update on key research and development and business objectives for the remainder of 2020.The conference call and presentation will be webcast live over the Internet and can be accessed by going to the “Events & Presentations” page under the “Investors & Media” section of the Celldex Therapeutics website at www.celldex.com. The call can also be accessed by dialing (800) 446-2782 (within the United States) or (847) 413-3235 (outside the United States)....
Progress Announces Participation in Tech Compact for Social Justice
Written by Customer Service on . Posted in Public Companies.
CEO Yogesh Gupta, founding signatory, member of the Executive Diversity and Inclusion Steering Committee and Co-Chair of the MassTLC Board of Trustees spearheads initiative to drive social justice in MassachusettsBEDFORD, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Progress (NASDAQ: PRGS), the leading provider of application development and digital experience technologies, today announced its participation in the newly formed Tech Compact for Social Justice, created under the leadership of the Executive Diversity and Inclusion Steering Committee (EDISC) of the MassTLC Board of Trustees as a way for the industry to come together and affect meaningful change. Progress CEO, Yogesh Gupta, was one of the framers, initial signatories and actively pursued the creation of the Compact as part of his role on the MassTLC Board of Trustees and...